Australia markets open in 6 hours 23 minutes

INVO Bioscience, Inc. (INVO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9800-0.0001 (-0.01%)
At close: 04:00PM EDT
0.9801 +0.00 (+0.01%)
After hours: 07:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.69M
Enterprise value 17.14M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.51
Price/book (mrq)5.97
Enterprise value/revenue 5.67
Enterprise value/EBITDA -2.49

Trading information

Stock price history

Beta (5Y monthly) 1.49
52-week change 3-85.96%
S&P500 52-week change 322.36%
52-week high 310.5000
52-week low 30.5000
50-day moving average 31.0587
200-day moving average 31.3964

Share statistics

Avg vol (3-month) 33.83M
Avg vol (10-day) 323.98M
Shares outstanding 52.74M
Implied shares outstanding 62.74M
Float 82.71M
% held by insiders 10.84%
% held by institutions 14.14%
Shares short (15 Apr 2024) 417.55k
Short ratio (15 Apr 2024) 40.7
Short % of float (15 Apr 2024) 40.67%
Short % of shares outstanding (15 Apr 2024) 40.67%
Shares short (prior month 15 Mar 2024) 411.03k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 309 Nov 2020
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 328 July 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -266.00%
Operating margin (ttm)-109.17%

Management effectiveness

Return on assets (ttm)-33.85%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)3.02M
Revenue per share (ttm)1.93
Quarterly revenue growth (yoy)396.80%
Gross profit (ttm)N/A
EBITDA -6.57M
Net income avi to common (ttm)-8.03M
Diluted EPS (ttm)-5.1300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)232.42k
Total cash per share (mrq)0.09
Total debt (mrq)8.68M
Total debt/equity (mrq)972.59%
Current ratio (mrq)0.15
Book value per share (mrq)-2.05

Cash flow statement

Operating cash flow (ttm)-4.76M
Levered free cash flow (ttm)641.46k